Urgent-Start Peritoneal Dialysis and Hemodialysis in ESRD Patients: Complications and Outcomes
Adult
Male
Time Factors
Adolescent
Science
Bacteremia
Comorbidity
03 medical and health sciences
0302 clinical medicine
Renal Dialysis
Risk Factors
Prevalence
Humans
Referral and Consultation
Aged
Retrospective Studies
Aged, 80 and over
Incidence
Q
R
Middle Aged
3. Good health
Survival Rate
Medicine
Kidney Failure, Chronic
Female
Peritoneal Dialysis
Research Article
DOI:
10.1371/journal.pone.0166181
Publication Date:
2016-11-08T13:40:41Z
AUTHORS (15)
ABSTRACT
Background Several studies have suggested that urgent-start peritoneal dialysis (PD) is a feasible alternative to hemodialysis (HD) in patients with end-stage renal disease (ESRD), but the impact of modality on outcome, especially short-term complications, has not been directly evaluated. The aim current study was compare complications and outcomes PD HD ESRD patients. Methods In this retrospective study, who initiated urgently without pre-established functional vascular access or catheter at single center from January 2013 December 2014 were included. Patients grouped according their (PD HD). Each patient followed for least 30 days after insertion (until 2016). Dialysis-related survival compared between two groups. Results Our enrolled 178 (56.2% male), whom 96 82 groups, respectively. Compared patients, had more cardiovascular disease, less heart failure, higher levels serum potassium, hemoglobin, albumin, pre-albumin, lower brain natriuretic peptide. There no significant differences gender, age, use steroids, early referral nephrologist, prevalence primary diseases, co-morbidities, other laboratory characteristics incidence dialysis-related during first significantly than probability bacteremia an independent predictor (30-day) complications. difference respect rate. Conclusion experienced center, safe urgent need dialysis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (25)
CITATIONS (60)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....